ACE2 and infection: We found that diltiazem treatment strongly inhibited SARS-CoV-2 internalization into Vero-E6-ACE2 cells and HEK293T cells at high and low infection doses while having no effect on SARS-CoV-2 binding to these two cell types (Fig 5B and 5C).